|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with EGFR x CD29 x LAMA4
100 Translational Medicine associated with EGFR x CD29 x LAMA4
0 Patents (Medical) associated with EGFR x CD29 x LAMA4